No. When a cell is removed (biopsied) from an embryo, cells are at the unspecialised state of growth and biopsied embryos will continue to develop into pregnancies and healthy babies.
Testing is performed by extracting and analysing a single or a few cells from the embryo. In doing so Genesis IVF can identify embryos that are healthy to be transferred, increasing pregnancy success rates.
Yes, in some ways, this technique may also be useful in the treatment of those couples whom have had recurrent pregnancy loss or recurrent implantation failures.
PGT offers couples with certain genetic disorders the chance to have a normal child.
Pre-implantation Genetic Testing (PGT) is a reproductive technology used with an In-Vitro Fertilization (IVF) cycle. It analyses the genetic profile of embryos before their transfer into the womb.
Research has shown that chromosome abnormalities can be common in eggs and with advancing age, a woman’s risk of having aneuploid (abnormal number of chromosome) eggs is greatly increased. Clinicians believe this is the main reason why birth rates fall for women in their late thirties and early forties.
It is rare, but if detected early it may be possible to remove an ectopic pregnancy without disturbing the pregnancy in the uterus.
No. An ectopic pregnancy must be removed, either medically or surgically.
All injectable medications need to be kept refrigerated during the course of your treatment. Your nurse coordinator will advise on the storage of your medications.
Some bloating and breast tenderness is common during the IVF process, but if it is excessively painful, you should discuss this with your doctor.